Caffeine’s Therapeutic Role in Neuropsychiatric Disorders

by Mohamed Fathima S on  January 8, 2019 at 11:39 AM Mental Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

The psychostimulant effects of caffeine could provide therapeutic benefits in the treatment of depression and other neuropsychiatric disorders, reveals the new research.
Caffeine’s Therapeutic Role in Neuropsychiatric Disorders
Caffeine’s Therapeutic Role in Neuropsychiatric Disorders

Caiffeine exerts its therapeutic action by targeting or blocking adenosine A2A receptor-dopamine D2 receptor (A2AR-D2R) and adenosine A1 receptor-dopamine D1 receptor (A1R-D1R).

Preclinical evidence is reviewed which indicates that caffeine and selective A2AR antagonists could be used to treat the motivational symptoms of depression as well as cognitive and emotional impairments in attention-deficit/hyperactivity disorder.

In addition, new research suggests that the A1R-D1R heteromer, which modulates the excitability of the spinal motoneuron, could be targeted by A1R antagonists to therapeutic effect in spinal cord injury.

Caffeine and selective adenosine receptor antagonists as potential new therapeutic tools are discussed in the article.

The article was published in Journal of Caffeine and Adenosine Research, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

More News on:

Rett Syndrome Walking Corpse Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive